OHSU, Spinout Najit, and WUSTL to Co-Develop West Nile Vaccine Using $7.3M NIAID Grant | GenomeWeb

Oregon Health and Science University said this week that it will collaborate with OHSU spinout Najit Technologies and Washington University in St. Louis to develop a vaccine for West Nile virus under a four-year, $7.3 million grant from the National Institute of Allergy and Infectious Diseases.

The partners, using a platform technology owned by OHSU and exclusively licensed to Najit, plan to create an inactivated formulation that remains highly immunogenic but may be safer to administer to immunocompromised patients than existing vaccines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.